RAS inhibitor

DRUG2 trials

Sponsors

The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Ruijin Hospital

Conditions

FinerenoneIgA NephropathyPrimary IgA NephropathyProteinuriaSafety Issues

Unknown Phase

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

CompletedNCT06460987

The Fourth Affiliated Hospital of Zhejiang University School of MedicineFinerenone, IgA Nephropathy, Proteinuria +1

Start: 2022-12-01End: 2024-03-31Updated: 2024-06-14

Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

CompletedNCT06589752

Ruijin HospitalPrimary IgA Nephropathy

Start: 2023-04-24End: 2024-09-05Updated: 2024-09-19

Related Papers

Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study

Clinical Kidney Journal2025-04-283 citations